These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations. Yourtee DM, Kirk-Yourtee CL. Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349 [Abstract] [Full Text] [Related]
4. Prophage induction by liver microsomal metabolites of aflatoxin B1 in lysogenic Pseudomonas aeruginosa. Patel IR, Rao KK. Acta Microbiol Hung; 1984 Oct; 31(4):359-64. PubMed ID: 6085605 [Abstract] [Full Text] [Related]
7. Conditions for induction of bacteriophage from lysogenic Bacillus megaterium with aflatoxin B1. Whittaker BL, Chipley JR. Appl Environ Microbiol; 1979 Mar; 37(3):554-8. PubMed ID: 110264 [Abstract] [Full Text] [Related]
13. Induction and mutagenesis of prophage lambda in Escherichia coli K12 by metabolites of aflatoxin B1. Goze A, Sarsin A, Moulé Y, Devoret R. Mutat Res; 1975 Apr; 28(1):1-7. PubMed ID: 1095913 [Abstract] [Full Text] [Related]
14. Genetic dependence of hepatic microsome-mediated depression of aflatoxin B1 activation to mutagens in Ames Salmonella typhimurium TA-98 system. Raina V, Gurtoo HL, Berrigan M, Paigen B. Biochem Biophys Res Commun; 1980 Jun 16; 94(3):737-43. PubMed ID: 6772179 [No Abstract] [Full Text] [Related]
15. The reduced mutagenicity of aflatoxin B1 due to hydroxylation: observations on five Salmonella typhimurium tester strains. Uwaifo AO, Bababunmi EA. Cancer Lett; 1979 Aug 16; 7(4):221-5. PubMed ID: 389414 [Abstract] [Full Text] [Related]
16. The effect of substrates and inhibitors of monoamine oxidase on hepatic dimethylnitrosamine metabolism and mutagenicity. Lake BG, Rowland IR, Harris RA, Collins MA, Phillips JC, Cottrell RC, Gangolli SD. Adv Exp Med Biol; 1981 Aug 16; 136 Pt B():1143-7. PubMed ID: 6283820 [No Abstract] [Full Text] [Related]
17. [Various aspects of the effect of nutritional factors on the metabolism and biological action of aflatoxin B1 in the rat liver]. Nikov PS, Parzian MS. Vopr Med Khim; 1985 Aug 16; 31(4):94-9. PubMed ID: 3931351 [Abstract] [Full Text] [Related]
18. A comparative study of monooxygenase activity in elasmobranchs and mammals: activation of the model pro-carcinogen aflatoxin B1 by liver preparations of calf, nurse shark and clearnose skate. Bodine AB, Luer CA, Gangjee S. Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985 Aug 16; 82(2):255-7. PubMed ID: 2866897 [Abstract] [Full Text] [Related]
19. Enhanced hepatotoxicity of aflatoxin B1 by pretreatment of rats with ethanol. Toskulkao C, Taycharpipranai S, Glinsukon T. Res Commun Chem Pathol Pharmacol; 1982 Jun 16; 36(3):477-91. PubMed ID: 6812183 [Abstract] [Full Text] [Related]
20. Aflatoxin M1: in vitro preparation and comparative in vitro metabolism versus aflatoxin B1 in the rat and mouse. Rice DW, Hsieh DP. Res Commun Chem Pathol Pharmacol; 1982 Mar 16; 35(3):467-90. PubMed ID: 6805048 [Abstract] [Full Text] [Related] Page: [Next] [New Search]